https://sma-europe.eu 2026-09-08T11:01:19.121Z weekly 1 https://sma-europe.eu/biogen 2025-09-23T09:45:10.332Z monthly 0.8 https://sma-europe.eu/krakow-2018 2025-06-17T14:44:58.063Z never 0.7 https://sma-europe.eu/sma-daily-life-study 2025-06-24T09:05:27.921Z monthly 0.8 https://sma-europe.eu/sma-events 2026-06-30T07:55:30.651Z monthly 0.8 https://sma-europe.eu/evry-2020 2025-06-17T14:43:45.775Z never 0.7 https://sma-europe.eu/drug-development 2025-06-17T14:17:14.179Z monthly 0.8 https://sma-europe.eu/odysma-supporters 2023-11-28T09:32:59.101Z yearly 0.5 https://sma-europe.eu/awareness2024 2024-09-19T15:29:07.773Z daily 0.9 https://sma-europe.eu/smart-horizon 2025-06-24T09:57:16.590Z monthly 0.8 https://sma-europe.eu/taldefgrobep-alfa 2025-09-23T08:32:23.582Z monthly 0.8 https://sma-europe.eu/sma-beyond 2022-02-28T10:41:25.980Z monthly 0.8 https://sma-europe.eu/biib-115 2025-09-23T09:39:15.714Z monthly 0.8 https://sma-europe.eu/sma-care-landscape 2023-07-19T08:05:37.760Z monthly 0.8 https://sma-europe.eu/nutrition-in-sma-1 2025-01-31T08:17:15.840Z monthly 0.8 https://sma-europe.eu/faqs-on-inheritance 2023-07-18T15:37:18.014Z yearly 0.5 https://sma-europe.eu/sma-europe-meets-early-career-researchers 2023-12-19T08:17:51.158Z monthly 0.8 https://sma-europe.eu/gym-329 2025-09-23T07:53:51.016Z monthly 0.8 https://sma-europe.eu/enmc 2022-02-28T10:03:55.738Z monthly 0.8 https://sma-europe.eu/sma-europe-youth-group 2026-10-21T10:08:47.707Z monthly 0.8 https://sma-europe.eu/fundamental-research 2023-07-18T15:41:45.988Z monthly 0.8 https://sma-europe.eu/nutrition-in-sma-online-workshop 2023-07-19T09:12:11.994Z never 0.7 https://sma-europe.eu/introduction-to-sma-research 2025-06-17T14:16:14.592Z monthly 0.8 https://sma-europe.eu/global-sm-advocacy-event 2024-06-24T08:53:47.961Z monthly 0.8 https://sma-europe.eu/roche 2025-09-23T10:02:52.965Z monthly 0.8 https://sma-europe.eu/sma-priority-setting-team 2024-05-30T08:03:00.265Z yearly 0.5 https://sma-europe.eu/about-sma 2025-07-14T09:56:26.779Z monthly 0.8 https://sma-europe.eu/about-us 2025-06-24T08:32:45.326Z monthly 0.8 https://sma-europe.eu/nmd-670 2025-09-23T09:42:05.637Z monthly 0.8 https://sma-europe.eu/care-standards-for-sma 2025-06-24T09:07:22.048Z monthly 0.8 https://sma-europe.eu/evrysdi 2025-06-17T14:25:18.627Z monthly 0.8 https://sma-europe.eu/sma-medicines-landscape 2026-05-21T14:33:50.607Z monthly 0.8 https://sma-europe.eu/novartis-gene-therapies 2025-09-23T10:06:05.721Z monthly 0.8 https://sma-europe.eu/scholar-rock 2025-08-20T11:16:41.491Z monthly 0.8 https://sma-europe.eu/zolgensma 2025-09-23T08:39:51.985Z monthly 0.8 https://sma-europe.eu/join-our-team 2025-05-13T09:56:29.434Z monthly 0.6 https://sma-europe.eu/our-partners 2025-06-24T10:54:00.510Z monthly 0.8 https://sma-europe.eu/spinraza 2025-06-24T08:58:38.476Z monthly 0.8 https://sma-europe.eu/barcelona-2022 2025-05-02T09:01:12.731Z never 0.7 https://sma-europe.eu/newborn-screening-in-sma 2026-05-21T14:40:09.781Z monthly 0.8 https://sma-europe.eu/our-priority-setting-project 2026-09-16T07:23:30.537Z monthly 0.8 https://sma-europe.eu/our-funding 2026-10-07T11:59:25.983Z monthly 0.8 https://sma-europe.eu/living-with-sma 2025-06-20T09:46:24.498Z monthly 0.8 https://sma-europe.eu/clinical-trials-for-sma 2025-09-23T11:40:43.137Z monthly 0.8 https://sma-europe.eu/sma-care-symposium 2025-10-01T10:25:12.897Z monthly 0.8 https://sma-europe.eu/awareness2026 2026-09-03T09:35:52.042Z monthly 0.8 https://sma-europe.eu/get-involved 2026-05-19T11:13:52.256Z yearly 0.7 https://sma-europe.eu/the-rolling-story-of-sma 2026-04-27T10:31:43.682Z monthly 0.8 https://sma-europe.eu/our-members 2026-09-10T09:50:50.630Z monthly 0.8 https://sma-europe.eu/donate 2026-05-19T11:13:31.814Z yearly 0.7 https://sma-europe.eu/one-goal-series 2026-09-15T14:04:25.380Z monthly 0.8 https://sma-europe.eu/awareness2023 2025-07-14T10:39:59.541Z daily 0.9 https://sma-europe.eu/5th-international-scientific-congress-on-spinal-muscular-atrophy 2026-04-20T10:17:14.673Z never 0.7 https://sma-europe.eu/clinical-care-symposium-prague-2027 2026-10-20T13:52:33.309Z monthly 0.8 https://sma-europe.eu/global-sm-advocacy-event-2026 2026-03-26T11:39:15.764Z monthly 0.8 https://sma-europe.eu/sm-academy-learning-opportunities-and-webinars 2026-10-20T14:05:15.399Z monthly 0.8 https://sma-europe.eu/4th-international-scientific-congress-on-spinal-muscular-atrophy 2025-04-24T08:36:45.182Z never 0.7 https://sma-europe.eu/anb-4 2025-06-17T14:35:27.511Z monthly 0.8 https://sma-europe.eu/spinal-cord-stimulator 2025-06-17T14:40:14.478Z monthly 0.8 https://sma-europe.eu/contact-us 2023-07-18T15:14:39.071Z monthly 0.6 https://sma-europe.eu/sma-europe-and-clinical-trial-readiness 2025-06-17T14:41:24.375Z monthly 0.8 https://sma-europe.eu/sma-patient-advocate-training 2026-09-22T11:06:18.627Z monthly 0.8 https://sma-europe.eu/combination-therapy 2023-07-19T08:25:21.417Z yearly 0.5 https://sma-europe.eu/oav-101 2025-09-23T09:59:39.956Z monthly 0.8 https://sma-europe.eu/sma-europe-annual-meetings-in-prague 2023-07-19T09:10:09.697Z never 0.7 https://sma-europe.eu/super-secret-test 2025-05-27T13:46:34.710Z monthly 0.8 https://sma-europe.eu/awareness2025 2025-09-04T07:38:51.609Z daily 0.9 https://sma-europe.eu/eupesma-series 2026-09-02T11:49:42.859Z yearly 0.7 https://sma-europe.eu/smacademy 2026-10-16T12:40:09.483Z monthly 0.8 https://sma-europe.eu/our-call-for-research-proposals 2026-10-01T08:14:11.135Z monthly 0.8 https://sma-europe.eu/our-people/board 2025-06-24T11:20:36.754Z monthly 0.8 https://sma-europe.eu/our-people/staff 2025-06-24T11:20:36.754Z monthly 0.8 https://sma-europe.eu/our-people/delegate 2025-06-24T11:20:36.754Z monthly 0.8 https://sma-europe.eu/our-people/committee 2025-06-24T11:20:36.754Z monthly 0.8 https://sma-europe.eu/scientific-advisory-board 2023-07-18T14:57:22.514Z monthly 0.8 https://sma-europe.eu/news/community-update-from-scholar-rock-fda-approval-of-isembyld-apitegromab-mstn 2026-09-15T07:46:43.503Z never 0.5 https://sma-europe.eu/news/community-update-novartis-receives-ec-market-authorisation-for-itvisma 2026-07-02T06:54:33.800Z never 0.5 https://sma-europe.eu/news/sma-europe-launches-the-annual-report-2025 2026-06-15T15:01:39.044Z never 0.5 https://sma-europe.eu/news/community-letter-from-nmd-pharma-completion-of-its-phase-2-synapse-sma-clinical-trial-of-ignaseclant-formerly-nmd-670 2026-06-12T07:58:04.754Z never 0.8 https://sma-europe.eu/news/community-update-fda-accepts-to-review-biologics-license-application-for-apitegromab 2026-05-14T11:16:11.704Z never 0.5 https://sma-europe.eu/news/community-update-novartis-receives-ema-chmp-positive-opinion-for-itvisma 2026-04-24T11:02:25.940Z never 0.5 https://sma-europe.eu/news/new-publication-two-decades-of-discovery-sma-research-from-darkness-to-hope-by-rare-revolution-magazine 2026-04-15T09:28:15.957Z never 0.5 https://sma-europe.eu/news/new-publication-a-seat-a-voice-a-vote-reimagining-the-role-of-sma-patient-advocates-in-research-and-care-by-rare-revolution-magazine 2026-04-15T09:28:08.107Z never 0.5 https://sma-europe.eu/news/new-publication-20-years-of-sma-europe-from-firefighting-to-future-building-by-rare-revolution-magazine 2026-04-15T09:27:20.979Z never 0.5 https://sma-europe.eu/news/community-letter-from-roche-chmp-positive-opinion-for-risdiplam-tablet-label-update 2026-03-30T09:53:33.150Z never 0.8 https://sma-europe.eu/news/community-update-roche-ema-approval-of-the-risdiplam-tablet 2026-03-26T08:37:19.278Z never 0.8 https://sma-europe.eu/news/community-update-roche-discontinuation-of-emugrobart-for-sma 2026-03-25T09:55:54.248Z never 0.5 https://sma-europe.eu/news/high-dose-regimen-of-nusinersen-receives-european-commission-approval-for-the-treatment-of-sma 2026-01-13T16:22:48.229Z never 0.5 https://sma-europe.eu/news/euesma-2023-survey-results 2025-12-01T10:43:00.570Z never 0.8 https://sma-europe.eu/news/breaking-news-fda-approval-for-itvisma-onasemnogene-abeparvovec-brve-the-intrathecal-formulation-of-onasemnogene-abeparvovec 2025-11-25T08:33:49.949Z never 0.5 https://sma-europe.eu/news/community-update-on-the-high-dose-regimen-of-nusinersen-in-the-treatment-of-sma-by-ema 2025-11-20T14:14:02.047Z never 0.5 https://sma-europe.eu/news/sma-europe-online-tool-helps-patients-find-clinical-trials-published-by-sma-news-today 2025-10-14T10:24:47.749Z never 0.8 https://sma-europe.eu/news/sma-europe-launched-new-clinical-trials-finder-to-support-access-to-clinical-trials-and-accelerate-progress-in-sma-treatment-published-by-rare-revolution-magazine 2025-10-14T10:16:11.206Z never 0.8 https://sma-europe.eu/news/community-update-fda-decision-on-the-high-dose-regimen-of-nusinersen-in-the-treatment-of-sma 2025-09-24T07:59:59.993Z never 0.5 https://sma-europe.eu/news/community-update-fda-decision-on-the-approval-of-scholar-rock-s-apitegromab 2025-09-23T14:53:01.840Z never 0.5 https://sma-europe.eu/news/community-update-biogen-salanersen-biib-115-study 2025-07-11T10:06:40.076Z never 0.8 https://sma-europe.eu/news/new-publication-spinal-cord-stimulation-a-new-perspective-for-sma-research-by-rare-revolution-magazine 2025-05-27T09:22:38.921Z never 0.8 https://sma-europe.eu/news/sma-news-today-latest-article-sma-europe-s-inaugural-gathering-to-discuss-medical-emergencies 2025-05-12T16:02:16.875Z never 0.8 https://sma-europe.eu/news/community-update-from-scholar-rock-1 2025-03-28T08:08:24.438Z never 0.5 https://sma-europe.eu/news/community-update-from-novartis-phase-iii-steer-and-phase-ii-ib-strength-studies 2025-03-21T08:34:39.040Z never 0.5 https://sma-europe.eu/news/community-update-from-roche-5 2025-03-21T08:31:30.151Z never 0.5 https://sma-europe.eu/news/call-for-research-no-12-learn-about-the-shortlisted-projects 2025-02-26T10:55:04.562Z never 0.5 https://sma-europe.eu/news/eupesma-2023-survey-is-now-rolling 2025-01-31T08:15:03.623Z never 0.8 https://sma-europe.eu/news/biohaven-s-resilient-letter-to-sma-community 2024-12-20T09:33:24.131Z never 0.5 https://sma-europe.eu/news/roche-s-end-of-year-community-letter 2024-12-20T09:28:34.925Z never 0.5 https://sma-europe.eu/news/sma-news-today-latest-article-sma-europe-inviting-patients-to-talk-of-how-treatment-has-changed-life 2024-12-19T08:58:40.145Z never 0.8 https://sma-europe.eu/news/celebrating-international-volunteers-day-honoring-our-incredible-volunteers 2024-12-19T08:53:56.167Z never 0.8 https://sma-europe.eu/news/access-to-spinal-muscular-atrophy-sma-treatment-in-denmark-a-success-story-of-how-persistence-can-win-in-the-end 2024-11-15T10:24:12.104Z never 0.5 https://sma-europe.eu/news/spinal-cord-stimulation-in-spinal-muscular-atrophy-research-study 2024-10-17T17:28:27.057Z never 0.5 https://sma-europe.eu/news/ody-sma-real-life-stories-presentation-at-brown-university 2024-10-17T15:53:55.579Z never 0.5 https://sma-europe.eu/news/one-community-shared-dreams-documentary-spotlight-sma-awareness-campaign 2024-09-11T14:37:06.928Z never 0.8 https://sma-europe.eu/news/new-partnership-with-rare-revolution-magazine-and-sma-news-today 2024-09-11T13:46:15.400Z never 0.8 https://sma-europe.eu/news/community-update-from-biogen-3 2024-09-04T13:10:05.316Z never 0.8 https://sma-europe.eu/news/new-partnership-with-eupati 2024-09-03T14:27:38.500Z never 0.8 https://sma-europe.eu/news/new-publication-systematic-literature-review-of-the-natural-history-of-spinal-muscular-atrophy 2024-08-30T11:29:48.506Z never 0.8 https://sma-europe.eu/news/end-of-year-2023-roche-s-community-update 2024-08-30T11:28:44.337Z never 0.8 https://sma-europe.eu/news/season-s-greetings-2023 2024-08-30T11:26:32.544Z never 0.8 https://sma-europe.eu/news/today-we-launch-care-for-adults-living-with-sma-in-europe-a-benchmarking-report 2024-08-30T11:25:30.862Z never 0.8 https://sma-europe.eu/news/community-update-from-biogen-2 2024-08-30T11:23:33.034Z never 0.8 https://sma-europe.eu/news/community-update-from-roche-3 2024-08-30T11:22:42.895Z never 0.8 https://sma-europe.eu/news/our-call-for-research-nr-12-is-now-open 2024-08-30T11:21:27.387Z never 0.8 https://sma-europe.eu/news/nmd-pharma-publishes-comprehensive-data-package-for-nmd-670-in-science-translational-medicine 2024-08-30T11:20:16.789Z never 0.8 https://sma-europe.eu/news/interview-with-bianca-ozcan-on-spinal-muscular-atrophy-and-4th-scientific-international-congress-in-ghent 2024-08-30T11:18:18.177Z never 0.8 https://sma-europe.eu/news/new-publication-spinal-muscular-atrophy-digital-spotlight-by-rare-revolution-magazine 2024-08-30T11:16:36.059Z never 0.8 https://sma-europe.eu/news/new-real-life-stories-on-ody-sma 2024-08-30T11:15:29.367Z never 0.8 https://sma-europe.eu/news/community-update-from-roche-4 2024-08-30T11:14:17.146Z never 0.8 https://sma-europe.eu/news/new-publication-at-rarity-life-magazine 2024-08-30T11:13:00.234Z never 0.8 https://sma-europe.eu/news/sma-europe-votes-the-new-board 2024-08-30T11:11:49.439Z never 0.8 https://sma-europe.eu/news/we-sign-the-all-to-action-on-the-imlementation-of-the-eu-joint-clinical-assessment-for-atmps 2024-08-30T11:10:28.396Z never 0.8 https://sma-europe.eu/news/our-annual-report-2023-is-now-live 2024-08-28T20:13:30.823Z never 0.8 https://sma-europe.eu/news/new-article-i-am-unique 2023-12-13T07:21:28.246Z never 0.5 https://sma-europe.eu/news/community-update-roche 2023-10-06T09:48:43.867Z never 0.8 https://sma-europe.eu/news/community-update-biohaven 2023-10-06T09:48:19.173Z never 0.8 https://sma-europe.eu/news/community-update-from-scholar-rock 2023-10-06T09:47:53.018Z never 0.8 https://sma-europe.eu/news/community-update-from-roche 2023-10-06T09:47:50.860Z never 0.4 https://sma-europe.eu/news/community-update-from-roche-2 2023-10-06T09:47:25.066Z never 0.8 https://sma-europe.eu/news/community-update-from-roche-1 2023-10-06T09:47:10.328Z never 0.8 https://sma-europe.eu/news/community-statement-biocad 2023-10-06T09:46:53.429Z never 0.8 https://sma-europe.eu/news/our-nbs-alliance-welcomes-twelve-members 2023-09-12T08:03:04.785Z never 0.4 https://sma-europe.eu/news/covid-19 2023-09-12T08:00:50.886Z never 0.4 https://sma-europe.eu/news/roche-completes-recruitment-for-jewelfish-clinical-trial 2023-09-12T07:59:43.625Z never 0.4 https://sma-europe.eu/news/risdiplams-firefish-meets-primary-endpoint-in-trial-in-infants-with-type-1-sma 2023-09-12T07:59:07.448Z never 0.4 https://sma-europe.eu/news/community-update-from-biogen-1 2023-07-18T15:52:18.578Z never 0.4 https://sma-europe.eu/news/scholar-rock-reports-preclinical-data-on-the-therapeutic-benefit-of-srk-015-in-models-of-sma 2023-07-18T15:49:40.224Z never 0.4 https://sma-europe.eu/news/scholar-rock-announces-positive-opinion-ema-orphan-drug-designation-srk-015-treatment-sma 2023-07-18T15:49:24.124Z never 0.4 https://sma-europe.eu/news/scholar-rock-announced-positive-interim-results-from-phase-1-trial-of-srk-015-in-healthy-volunteers-and-updates-on-future-development-plans 2023-07-18T15:48:45.603Z never 0.4 https://sma-europe.eu/news/potential-biomarker-for-sma-identified 2023-07-18T15:47:55.045Z never 0.4 https://sma-europe.eu/news/data-published-in-neurology-suggest-long-term-benefit-of-spinraza-treatment-in-later-onset-sma-including-sma-type-iii 2023-07-18T15:47:13.909Z never 0.4 https://sma-europe.eu/news/pre-symptomatic-infants-treated-with-spinraza-achieve-motor-milestones-more-consistent-with-normal-development 2023-07-18T15:46:50.247Z never 0.4 https://sma-europe.eu/news/roche-presented-data-from-its-risdiplam-pivotal-firefish-and-sunfish-studies-at-the-2019-aan-annual-meeting 2023-07-18T15:46:23.381Z never 0.4 https://sma-europe.eu/news/novartis-announced-that-enrollment-for-the-ongoing-clinical-trial-of-branaplan-is-now-closed 2023-07-18T15:45:56.070Z never 0.4 https://sma-europe.eu/news/avexis-presents-positive-interim-results-on-zolgensma-across-a-broad-spectrum-of-patients-with-sma 2023-07-18T15:45:00.155Z never 0.4 https://sma-europe.eu/news/avexis-receives-fda-approval-for-zolgensma-the-first-gene-therapy-for-paediatric-patients-with-sma 2023-07-18T15:44:33.169Z never 0.4 https://sma-europe.eu/news/potential-sma-treatment-granted-orphan-medicinal-product-designation-by-the-european-medicines-agency-ema 2023-07-18T15:44:07.926Z never 0.4 https://sma-europe.eu/news/a-community-update-from-biogen 2023-07-18T15:43:48.342Z never 0.4 https://sma-europe.eu/news/biogen-announces-new-nusinersen-trial-in-broad-patient-population 2023-07-18T15:42:56.099Z never 0.4 https://sma-europe.eu/news/fda-puts-partial-hold-on-avxs-101-intrathecal-clinical-trials-for-sma 2023-07-18T15:39:56.852Z never 0.4 https://sma-europe.eu/news/sma-europe-awards-4-new-grants-to-cutting-edge-research-projects 2023-07-18T15:39:30.154Z never 0.4 https://sma-europe.eu/news/roches-risdiplam-meets-primary-endpoint-in-pivotal-sunfish-trial-in-people-with-type-2-or-3-sma 2023-07-18T15:39:06.198Z never 0.4 https://sma-europe.eu/news/jane-velkovski-11-year-old-disability-advocate-speaks-at-the-united-nations-on-world-childrens-day 2023-07-18T15:38:39.882Z never 0.4 https://sma-europe.eu/news/fda-grants-priority-review-to-risdiplam-for-the-treatment-of-sma 2023-07-18T15:37:03.664Z never 0.4 https://sma-europe.eu/news/avxs-101-zolgensma-to-be-made-available-globally-through-a-controversial-programme 2023-07-18T15:36:42.018Z never 0.4 https://sma-europe.eu/news/roche-announces-global-pre-approval-access-compassionate-use-paa-cu-plans-for-risdiplam 2023-07-18T15:36:15.519Z never 0.4 https://sma-europe.eu/news/risdiplam-shown-to-improve-motor-function-in-people-aged-2-to-25-with-type-2-or-3-sma 2023-07-18T15:35:36.576Z never 0.4 https://sma-europe.eu/news/european-medicines-agency-grants-positive-recommendation-for-conditional-marketing-authorisation-of-gene-therapy-product-onasemnogene-abeparvovec-zolgensma 2023-07-18T15:34:33.299Z never 0.4 https://sma-europe.eu/news/euro-nmd-survey-covid19 2023-07-18T15:34:11.303Z never 0.4 https://sma-europe.eu/news/roche-provides-an-update-on-the-clinical-development-of-risdiplam 2023-07-18T15:33:34.380Z never 0.4 https://sma-europe.eu/news/devote-trial-first-patient-treated 2023-07-18T15:33:18.552Z never 0.4 https://sma-europe.eu/news/roches-risdiplam-shows-significant-improvement-in-survival-and-motor-milestones-in-infants-with-type-1-sma 2023-07-18T15:32:52.716Z never 0.4 https://sma-europe.eu/news/2357-2 2023-07-18T15:32:24.492Z never 0.4 https://sma-europe.eu/news/zolgensma-the-first-gene-therapy-to-treat-sma-receives-conditional-marketing-authorisation-in-the-european-union 2023-07-18T15:31:53.815Z never 0.4 https://sma-europe.eu/news/roche-presents-new-data-on-sunfish-jewelfish-trials-at-the-cure-sma-annual-2020-virtual-conference 2023-07-18T15:31:25.135Z never 0.4 https://sma-europe.eu/news/biogen-initiates-new-respond-trial 2023-07-18T15:31:03.364Z never 0.4 https://sma-europe.eu/news/uk-sma-research-online-conference-10th-11-september-2020 2023-07-18T15:29:54.502Z never 0.4 https://sma-europe.eu/news/risdiplam-approved-for-the-treatment-of-sma-in-the-us 2023-07-18T15:29:27.976Z never 0.4 https://sma-europe.eu/projects/uncovering-the-mechanism-of-action-and-synergistic-potential-of-an-sma-repositioned-therapy 2026-01-22T12:03:01.916Z yearly 0.8 https://sma-europe.eu/projects/nuclear-and-cytoplasmic-phase-separation-enable-novel-functions-of-the-smn-complex-in-rnp-homeostasis 2026-01-22T12:02:55.375Z yearly 0.8 https://sma-europe.eu/projects/investigating-microvasculopathy-in-sma-patients-and-their-response-to-nusinersen-onasemnogene-abeparvovec-and-risdiplam 2026-01-22T12:02:47.964Z yearly 0.8 https://sma-europe.eu/projects/the-role-of-smn-in-macrophage-differentiation-and-cytokine-expression-as-well-as-in-surfactant-clearance-in-lungs-of-sma-mice 2026-01-22T12:02:38.962Z yearly 0.8 https://sma-europe.eu/projects/are-vascular-defects-important-in-sma 2026-01-22T12:02:00.620Z yearly 0.8 https://sma-europe.eu/projects/unravelling-the-role-of-stathmin-2-in-sma-as-a-key-a-key-cause-of-motor-neuron-vulnerability-and-as-a-therapeutic-target 2026-01-22T12:01:43.668Z yearly 0.8 https://sma-europe.eu/projects/sma-mechanisms-implicated-in-the-perturbation-of-the-calcium-homeostasis-and-essay-of-a-new-therapeutic-molecular-target 2026-01-22T12:01:35.827Z yearly 0.8 https://sma-europe.eu/projects/molecular-mechanisms-of-synaptic-transmission-of-the-sensory-motor-circuit-in-spinal-muscular-atrophy 2026-01-22T12:01:28.049Z yearly 0.8 https://sma-europe.eu/projects/a-network-biology-based-approach-for-the-development-of-smn-independent-treatments 2026-01-22T12:01:20.849Z yearly 0.8 https://sma-europe.eu/projects/seeking-small-molecules-that-stabilise-protein-rna-interactions-to-cure-spinal-muscular-atrophy 2026-01-22T12:00:43.811Z yearly 0.8 https://sma-europe.eu/projects/role-of-a-redox-sensor-in-nuclear-organisation-and-its-implication-in-spinal-muscular-atrophy 2026-01-22T12:00:35.212Z yearly 0.8 https://sma-europe.eu/projects/using-rna-secondary-structure-as-a-therapeutic-target-for-spinal-muscular-atrophy-a-new-drug-discovery-approach 2026-01-22T12:00:09.010Z yearly 0.8 https://sma-europe.eu/projects/modulating-smn2-splicing-with-dual-inhibitors-of-sam68-and-hnrnp-a1-a-novel-therapeutic-approach-for-spinal-muscular-atrophy 2026-01-22T11:59:59.194Z yearly 0.8 https://sma-europe.eu/projects/elucidate-the-molecular-mechanism-underlying-maturation-and-remodelling-defects-of-the-neuromuscular-system-in-sma-2 2026-01-22T11:59:39.385Z yearly 0.8 https://sma-europe.eu/projects/aav9-mediated-gene-therapy-in-murine-and-feline-models-of-sma 2026-01-22T11:59:20.504Z yearly 0.8 https://sma-europe.eu/projects/delivery-and-correction-of-sma-using-aav-vectors 2026-01-22T11:59:07.883Z yearly 0.8 https://sma-europe.eu/projects/new-drugs-and-new-drug-targets-for-spinal-muscular-atrophy-using-chemical-and-functional-genomics 2026-01-22T11:58:56.643Z yearly 0.8 https://sma-europe.eu/projects/pten-modulation-effects-on-motor-neuron-axonal-growth-and-neuromuscular-junction-size-in-spinal-muscular-atrophy 2026-01-22T11:58:08.182Z yearly 0.8 https://sma-europe.eu/projects/gene-therapy-for-spinal-muscular-atrophy-by-a-correction-of-smn2-mrna-splicing 2026-01-22T11:57:55.618Z yearly 0.8 https://sma-europe.eu/projects/evaluation-of-new-aav-mediated-gene-therapy-strategies-in-a-feline-model-of-spinal-muscular-atrophy 2026-01-22T11:57:48.709Z yearly 0.8 https://sma-europe.eu/projects/antisense-oligomer-induced-restoration-of-expression-as-a-therapy-for-spinal-muscular-atrophy 2026-01-22T11:57:40.571Z yearly 0.8 https://sma-europe.eu/projects/evaluation-of-aav-mediated-gene-therapy-in-murine-and-feline-sma-models 2026-01-22T11:57:15.891Z yearly 0.8 https://sma-europe.eu/projects/development-of-a-stem-cell-approach-for-treating-spinal-muscular-atrophy 2026-01-22T11:57:05.050Z yearly 0.8 https://sma-europe.eu/projects/defining-the-role-of-the-motor-axon-translatome-in-sma-pathogenesis 2026-01-06T09:02:24.728Z yearly 0.8 https://sma-europe.eu/projects/combinatorial-aso-therapy-using-smn-dependent-and-smn-independent-protection-against-sma 2026-01-06T09:02:11.517Z yearly 0.8 https://sma-europe.eu/projects/restoring-disturbed-energy-homeostasis-in-sma-motor-neurons 2026-01-06T09:01:41.425Z yearly 0.8 https://sma-europe.eu/projects/regulation-of-smn-function-in-sma 2026-01-06T08:52:59.002Z yearly 0.8 https://sma-europe.eu/projects/the-rock-erk-signalling-network-in-sma-mediator-of-neurodegeneration-and-smn-independent-treatment-target 2026-01-06T08:52:33.664Z yearly 0.8 https://sma-europe.eu/projects/determining-the-temporal-spatial-and-molecular-signature-of-hypoxia-in-spinal-muscular-atrophy 2026-01-06T08:52:10.932Z yearly 0.8 https://sma-europe.eu/projects/study-of-the-role-of-smn-in-the-regulation-of-muscle-resident-progenitors-for-the-identification-of-novel-therapeutic-targets-for-sma 2026-01-06T08:50:59.595Z yearly 0.8 https://sma-europe.eu/projects/identification-of-micrornas-as-biomarkers-and-potential-therapeutic-targets-in-spinal-muscular-atrophy 2026-01-06T08:49:45.708Z yearly 0.8 https://sma-europe.eu/projects/a-spinal-muscular-atrophy-drosophila-model-for-in-vivo-drug-discovery 2026-01-06T08:49:31.325Z yearly 0.8 https://sma-europe.eu/projects/cellular-basis-of-motor-circuit-dysfunction-induced-by-smn-deficiency-2 2026-01-06T08:48:37.864Z yearly 0.8 https://sma-europe.eu/projects/optimization-of-aav9-smn-gene-therapy-for-sma 2026-01-06T08:37:34.010Z yearly 0.8 https://sma-europe.eu/projects/in-search-of-small-molecules-targeting-protein-rna-complex 2026-01-06T08:36:16.760Z yearly 0.8 https://sma-europe.eu/projects/spinal-muscular-atrophy-molecular-and-functional-analysis-of-a-new-modifier-of-sma 2026-01-06T08:35:02.056Z yearly 0.8 https://sma-europe.eu/projects/investigating-novel-genetic-determinants-of-the-sma-phenotype 2026-01-06T08:34:38.748Z yearly 0.8 https://sma-europe.eu/projects/exosome-delivery-of-splice-switching-oligonucleotides-for-the-treatment-of-spinal-muscular-atrophy 2026-01-06T08:34:25.035Z yearly 0.8 https://sma-europe.eu/projects/mrna-transport-in-sma-pathogenesis 2026-01-06T08:34:12.200Z yearly 0.8 https://sma-europe.eu/projects/aav9-mediated-gene-therapy-in-murine-models-of-sma 2026-01-06T08:33:24.407Z yearly 0.8 https://sma-europe.eu/projects/evalation-of-the-contribution-of-smn1-and-smn2-sequence-variants-to-the-clinical-severity-of-sma 2026-01-06T08:27:44.261Z yearly 0.8 https://sma-europe.eu/projects/analysis-of-m-rna-transport-and-local-protein-syntheses-in-axons-of-sma-motor-neurons 2026-01-06T08:25:08.767Z yearly 0.8 https://sma-europe.eu/projects/the-s-pombe-model-organism-tool-to-find-suppressors-of-snrnp-mediated-splicing-defects 2026-01-06T08:22:46.600Z yearly 0.8 https://sma-europe.eu/projects/invastigating-the-temporal-requirements-of-the-smn-protein-in-spinal-muscular-atrophy 2026-01-06T08:22:07.077Z yearly 0.8 https://sma-europe.eu/projects/outcome-measures-in-sma-types-ii-and-iii 2026-01-06T08:20:05.851Z yearly 0.8 https://sma-europe.eu/projects/characterization-of-post-transcriptional-control-mechanisms-regulating-smn2-gene-expression 2026-01-06T08:19:57.980Z yearly 0.8 https://sma-europe.eu/projects/a-two-pronged-approach-to-develop-a-treatment-for-spinal-muscular-atrophy 2026-01-06T08:19:04.691Z yearly 0.8 https://sma-europe.eu/projects/skeletal-muscle-stem-cells-as-untapped-therapeutic-targets-for-sma-long-term-treatment-satsma 2025-02-28T14:21:17.235Z yearly 0.8 https://sma-europe.eu/projects/investigating-calcium-induced-mitochondrial-dysfunction-in-zebrafish-and-i-psc-models-of-sma 2025-02-27T14:02:20.332Z yearly 0.8 https://sma-europe.eu/projects/leveraging-smn-role-in-translation-to-develop-the-next-gen-of-biomarkers-for-sma 2025-02-27T13:58:49.397Z yearly 0.8 https://sma-europe.eu/projects/are-microvascular-defects-relevant-in-spinal-muscular-atrophy-characterisation-of-the-mouse-model 2025-02-27T13:57:37.703Z yearly 0.8 https://sma-europe.eu/projects/deciphering-the-molecular-landscape-of-neuromuscular-development-in-spinal-muscular-atrophy 2025-02-27T13:56:42.343Z yearly 0.8 https://sma-europe.eu/news 2026-09-15T07:46:43.503Z weekly 0.6 https://sma-europe.eu/projects 2026-01-22T12:03:01.916Z monthly 0.6 https://sma-europe.eu/search daily 0.3 https://sma-europe.eu/resources monthly 0.8 https://sma-europe.eu/news/category/newsletters monthly 0.3 https://sma-europe.eu/news/category/ukraine monthly 0.3 https://sma-europe.eu/news/category/advocacy monthly 0.3 https://sma-europe.eu/news/category/ody-sma monthly 0.3 https://sma-europe.eu/news/category/rare-diseases monthly 0.3 https://sma-europe.eu/news/category/treatments monthly 0.3 https://sma-europe.eu/news/category/other monthly 0.3 https://sma-europe.eu/news/category/clinical-trials monthly 0.3 https://sma-europe.eu/news/category/members monthly 0.3 https://sma-europe.eu/news/category/therapy-and-care monthly 0.3 https://sma-europe.eu/news/category/clinical-trials-initiatives monthly 0.3 https://sma-europe.eu/news/category/research monthly 0.3 https://sma-europe.eu/news/category/meetings-and-conferences monthly 0.3 https://sma-europe.eu/news/category/sma-events monthly 0.3 https://sma-europe.eu/news/category/therapy-investigation monthly 0.3 https://sma-europe.eu/resources/newsletters monthly 0.3 https://sma-europe.eu/resources/ukraine monthly 0.3 https://sma-europe.eu/resources/advocacy monthly 0.3 https://sma-europe.eu/resources/rare-diseases monthly 0.3 https://sma-europe.eu/resources/treatments monthly 0.3 https://sma-europe.eu/resources/other monthly 0.3 https://sma-europe.eu/resources/clinical-trials monthly 0.3 https://sma-europe.eu/resources/members monthly 0.3 https://sma-europe.eu/resources/therapy-and-care monthly 0.3 https://sma-europe.eu/resources/clinical-trials-initiatives monthly 0.3 https://sma-europe.eu/resources/research monthly 0.3 https://sma-europe.eu/resources/meetings-and-conferences monthly 0.3 https://sma-europe.eu/resources/sma-events monthly 0.3 https://sma-europe.eu/resources/therapy-investigation monthly 0.3